Urinary activin A test for kidney injury severity
Part of Kidney & urinary clinical trials.
This trial checks if a substance called activin A, found in urine, can help doctors predict how serious acute kidney injury (sudden kidney damage) is in patients. The goal is to find a better way to measure kidney injury severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have acute kidney injury (sudden kidney damage).
- You must not have a history of chronic kidney disease (long-term kidney problems).
- You must not have any condition that increases activin A levels, such as heart failure, cancer, COPD (chronic lung disease), systemic sclerosis (a rare connective tissue disease), or be pregnant.
- You must not have certain viral infections, Mycosis Fungoides or Sézary Syndrome (rare skin lymphomas).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests software that uses artificial intelligence to predict if a patient in the ICU might develop acute kidney injury (sudden kidney damage). It aims to see if the software is cost-effective and could help doctors catch problems earlier.
This study measures a protein called uromodulin in the blood of patients with sepsis and acute kidney injury (AKI) to see if it can help predict outcomes. It aims to find a better way to assess kidney damage early.
This study tests a urine test that may help detect kidney injury early in ICU patients. Early detection could lead to quicker treatment and better outcomes.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This study uses a non-invasive ultrasound of the kidneys (renal Doppler) to see if it can predict acute kidney injury—sudden kidney damage—in patients who are on a ventilator for ARDS. If you qualify, you will help doctors learn a safer way to monitor kidney health.
This study looks at people with acute (sudden) kidney injury, based on changes in a blood test called creatinine. By tracking these patterns during hospitalization, it may help improve how acute kidney injury is identified and managed.
Hear when a new Urinary Activin A in AKI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.